Pulmonary embolism prevalence among emergency department cohorts: A systematic review and meta-analysis by country of study.

Autor: Germini F; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.; Division of Emergency Medicine, Department of Medicine, McMaster University, Hamilton, Canada.; Department of Health Sciences, Università degli Studi di Milano, Milano, Italy., Zarabi S; Division of Emergency Medicine, Department of Medicine, McMaster University, Hamilton, Canada., Eventov M; Division of Emergency Medicine, Department of Medicine, McMaster University, Hamilton, Canada., Turcotte M; Division of Emergency Medicine, Department of Medicine, McMaster University, Hamilton, Canada., Li M; Division of Emergency Medicine, Department of Medicine, McMaster University, Hamilton, Canada., de Wit K; Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada.; Division of Emergency Medicine, Department of Medicine, McMaster University, Hamilton, Canada.
Jazyk: angličtina
Zdroj: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Jan; Vol. 19 (1), pp. 173-185. Date of Electronic Publication: 2020 Nov 18.
DOI: 10.1111/jth.15124
Abstrakt: Essentials The threshold to test for pulmonary embolism (PE) might be lower in North America than Europe. We compared the PE prevalence and positive yield of imaging in Europe and North America. More patients tested in Europe are diagnosed with PE, and imaging is more often positive. Our systematic review supports the hypothesis of overtesting for PE in North America. ABSTRACT: Background There is an impression that North American emergency department (ED) patients tested for pulmonary embolism (PE) differ from European ones. Objectives We compared the PE prevalence, frequency of use, and positive yield of imaging among ED patients tested for PE in Europe and North America. Methods We searched for studies reporting consecutive ED patients tested for PE. Two authors screened full texts, performed risk of bias assessment, and data extraction. We conducted a meta-analysis of proportions for each outcome and a multiple meta-regression. Results From 3109 publications, 44 were included in the systematic review. The prevalence of PE in Europe was 23% (95% confidence interval [CI], 21-26) and in North America 8% (95% CI, 6-9). The adjusted mean difference (aMD) in the prevalence of PE in the European compared with North American studies, was 15% (95% CI, 10-20). Computed tomography pulmonary angiography (CTPA) was used in 60% (95% CI, 52%-68) of European and 38% (95% CI, 24-51) of North American patients tested for PE (aMD, 23% [95% CI, 7-39]). The CTPA diagnostic yield was 29% (95% CI, 26-32) in Europe and 13% (95% CI, 9-17) in North America (aMD, 15% [95% CI, 8-21]). Conclusion Compared with North America, European ED studies have a higher prevalence of PE and diagnostic yield from CTPA, despite a higher frequency of CTPA use among patients tested for PE. This supports the hypothesis that those tested for PE in North American EDs have a lower risk of PE compared with Europe.
(© 2020 International Society on Thrombosis and Haemostasis.)
Databáze: MEDLINE
Externí odkaz: